SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-105243
Filing Date
2020-09-15
Accepted
2020-09-15 16:20:56
Documents
3
Period of Report
2020-09-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2030894d1_8k.htm 8-K 18715
2 EXHIBIT 99.1 tm2030894d1_ex99-1.htm EX-99.1 10964
3 GRAPHIC image_001.jpg GRAPHIC 3949
  Complete submission text file 0001104659-20-105243.txt   36661
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36435 | Film No.: 201176215
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences